SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurogen (NRGN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (471)6/25/2007 5:51:54 PM
From: keokalani'nui  Read Replies (1) of 523
 
I own some nrgn but I don't feel particularly 'up on it'. That is a sad admission, true. (For example, I had no idea the obesity trial--did you say--was stopped by dsmb????)

Agree with you, seems sleep programs everywhere are not worth nearly as much as they were before all of the circumstances of lunesta, indiplon and generic ambien occured. Companies in the space probably won't get credit for them until they hit the market.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News